Neuroendocrine Tumors Panel - Disclosures as of 5/19/2013
View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures| Panel Member | Clinical Research Support | Advisory Boards, Speakers Bureau, Expert Witness, or Consultant | Patent, Equity, or Royalty | Other | Date Completed |
|---|---|---|---|---|---|
Al B. Benson III, MD, FACP |
Abbott Laboratories; |
Agendia BV; |
None |
None |
8/31/2012 |
Emily Bergsland, MD |
Genentech, Inc.; |
Novartis Pharmaceuticals Corporation |
None |
None |
10/14/2012 |
Jordan D. Berlin, MD |
Abbott Laboratories; |
AstraZeneca Pharmaceuticals LP; |
None |
None |
12/9/2012 |
Lawrence S. Blaszkowsky, MD |
Genentech, Inc.; |
None |
None |
None |
9/28/2011 |
Michael A. Choti, MD, MBA |
None |
Bayer HealthCare; |
None |
None |
2/12/2013 |
Orlo H. Clark, MD |
Xoma |
Xoma |
None |
None |
3/8/2013 |
Mary Dwyer, MS |
None |
None |
None |
None |
3/26/2013 |
Lyska Emerson, MD |
None |
None |
None |
None |
8/9/2012 |
Paul F. Engstrom, MD, FACP |
None |
None |
None |
None |
2/27/2013 |
Deborah Freedman-Cass, PhD |
None |
None |
None |
None |
3/7/2013 |
Lauren Gallagher, RPh, PhD |
None |
None |
None |
None |
6/5/2012 |
Whitney S. Goldner, MD |
None |
None |
None |
None |
11/14/2012 |
Kristina M. Gregory, RN, MSN, OCN |
None |
None |
None |
None |
10/23/2012 |
Martin J. Heslin, MD |
None |
None |
None |
None |
10/8/2012 |
Fouad Kandeel, MD, PhD |
None |
None |
None |
None |
8/17/2012 |
Matthew H. Kulke, MD |
None |
Novartis Pharmaceuticals Corporation; |
None |
None |
8/9/2012 |
Pamela L. Kunz, MD |
Genentech, Inc.; |
None |
None |
None |
9/3/2012 |
Boris W. Kuvshinoff, MD, MBA |
None |
None |
None |
None |
10/24/2012 |
Joan S. McClure, MS |
None |
None |
None |
None |
7/23/2012 |
Jeffrey F. Moley, MD |
AstraZeneca Pharmaceuticals LP; |
Exelixis Inc. |
None |
None |
10/8/2012 |
Gitonga Munene, MD |
Pending |
||||
Venu G. Pillarisetty, MD |
None |
None |
None |
None |
8/16/2012 |
Leonard Saltz, MD |
Amgen Inc.; |
Bayer HealthCare; |
None |
None |
8/27/2012 |
David E. Schteingart, MD |
Corcept Therapeutics |
None |
None |
None |
4/9/2012 |
Manisha H. Shah, MD |
National Cancer Institute; |
Novartis Pharmaceuticals Corporation |
None |
None |
8/20/2012 |
Jonathan R. Strosberg, MD |
Genentech, Inc.; |
Genentech, Inc.; |
None |
None |
11/9/2012 |
Jean-Nicolas Vauthey, MD |
None |
None |
None |
None |
9/13/2012 |
Rebekah White, MD |
None |
None |
None |
None |
2/3/2012 |
James C. Yao, MD |
Genentech, Inc.; |
National Cancer Institute; |
None |
None |
11/28/2012 |
About NCCN| NCCN Member Institutions| Patient Resources| NCCN Foundation| Privacy Policy| Legal Notices| Contact Us
275 Commerce Drive, Suite 300, Fort Washington, PA 19034 • 215.690.0300 • Fax: 215.690.0260
Copyright © 2012 National Comprehensive Cancer Network, All Rights Reserved